semaglutide urinary side effects and UTI: does GLP-1 therapy increase tract infection risk? Comparative safety and side effects

GLP-1GLP-1YBC

Semaglutide has emerged as a revolutionary weight loss treatment, helping many people achieve their weight loss goals effectively

Introduction Given the global increase in obesity prevalence, there has been an emergence of a multitude of treatment options, specifically less invasive operations, like intragastric balloons, and pharmaceutical treatments like semaglutide

Both incretin antibody titers were significantly higher in patients with diabetes than in healthy controls (both P<0.01)

Be non-inflammatory

And here we see in IQVIAs two charts the declining share of traditional diabetes therapies with growing new prescriptions for GLP-1 agonists a 5% share in 2019 and a 16% share in 2023